Charming Medical (MCTA) CEO reports 91.65% voting control stake

Rhea-AI Filing Summary

Kit Wong has filed a Schedule 13D disclosing a controlling stake in Charming Medical Ltd. She beneficially owns 10,350,360 Class A ordinary shares and 2,000,000 Class B ordinary shares, giving her approximately 91.65% of the company’s aggregate voting power.

The Class A shares carry one vote per share and the Class B shares carry twenty votes per share, based on 14,938,000 Class A and 2,000,000 Class B shares outstanding. Wong, the company’s CEO, director, and board chair, notes she is a pre-IPO shareholder and holds the securities with the intent to exercise control, and reports no transactions in the past sixty days and no specific additional plans beyond this control position.

Insights

Corporate governance analyst

Charming Medical has an extremely concentrated voting structure under its CEO.

Ms. Kit Wong’s Schedule 13D shows she controls about 91.65% of Charming Medical’s total voting power through Class A and super-voting Class B shares. This effectively gives her decisive influence over shareholder decisions and board composition.

The filing also states she is a pre-IPO shareholder and intends to exercise control, while having no recent share transactions and no detailed additional plans listed under the standard Schedule 13D categories. Future corporate actions and governance outcomes will largely reflect her strategic preferences, given this level of control.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

Charming Medical Ltd

(Name of Issuer)

Class A Ordinary shares, par value $0.0001 per share

(Title of Class of Securities)

(CUSIP Number)

c/o Kit Wong
Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street
Causeway Bay, K3, 0000
852 2116 1492

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

10/22/2025

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP No.

1

Name of reporting person

Kit Wong

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

PF

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

HONG KONG

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 10,350,360.00
8	Shared Voting Power 0.00
9	Sole Dispositive Power 10,350,360.00
10	Shared Dispositive Power 0.00

11

Aggregate amount beneficially owned by each reporting person

10,350,360.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

69.29 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

Note to Lines 11 and 13: Kit Wong (the "Reporting Person") is an individual who beneficially owns 10,350,360 class A ordinary shares and 2,000,000 class B ordinary shares of Charming Medical Limited (the "Issuer"), representing approximately 91.65% of the aggregate voting power of the Issuer's issued and outstanding Class A and Class B Ordinary Shares. Each of the class A ordinary shares has one vote per share, while each of the class B ordinary shares has twenty (20) votes per share. Note to Line 13: The calculation is based on 14,938,000 class A ordinary shares and 2,000,000 class B ordinary shares of the Issuer, as reported in the Issuer's prospectus on Form 424B4 filed with the U.S. Securities and Exchange Commission (the "SEC") on October 21, 2025 and the report on Form 6-K filed with the SEC on October 22, 2025.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Class A Ordinary shares, par value $0.0001 per share
(b)	Name of Issuer: Charming Medical Ltd
(c)	Address of Issuer's Principal Executive Offices: Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, HONG KONG , 0000.
Item 2.	Identity and Background
(a)	Kit Wong
(b)	Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong
(c)	The Reporting Person is the Chief Executive Officer, Director, and Chairman of the Board of the Issuer. The address of the Issuer is Units 1803-1806, 18/F, Hang Lung Centre, 2-20 Paterson Street, Causeway Bay, Hong Kong.
(d)	During the last five years, the Reporting Person has not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	During the last five years, the Reporting Person has not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f)	Ms. Kit Wong is a citizen of Hong Kong.
Item 3.	Source and Amount of Funds or Other Consideration
	PF
Item 4.	Purpose of Transaction
	The Reporting Person is pre-IPO shareholder of the Issuer. The Reporting Person acquired and continues to hold the securities with the intent to exercise control over the Issuer. Except as set forth herein, the Reporting Person does not have any present plans or proposals which relate to or would result in any of the transactions described in paragraphs (a) through (j) of this Item 4.
Item 5.	Interest in Securities of the Issuer
(a)	Incorporated by reference to Lines 11 and 13 of the Cover Page. As of the date hereof, Ms. Kit Wong is deemed to beneficially own 10,350,360 class A ordinary shares and 2,000,000 class B ordinary shares of Charming Medical Limited (the "Issuer"), representing approximately 91.65% of the aggregate voting power of the Issuer's issued and outstanding share capital, based on 14,938,000 class A ordinary shares and 2,000,000 class B ordinary shares, as reported in the Issuer's prospectus on Form 424B4 filed with the SEC on October 21, 2025 and the report on Form 6-K filed with the SEC on October 22, 2025.
(b)	Incorporated by reference to Lines 7-10 of the Cover Page.
(c)	The Reporting Person has not engaged in any transactions in the class of securities reported on that were effected during the past sixty days.
(d)	N/A
(e)	N/A
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Except as set forth herein, the Reporting Person has no contracts, arrangements, understandings, or relationships with respect to the Issuer's securities requiring disclosure under this Item 6.
Item 7.	Material to be Filed as Exhibits.
	Except as set forth herein, there are no material agreements, contracts, arrangements, or understandings that require filing as exhibits under this Item 7.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Kit Wong

Signature:	/s/ Kit Wong
Name/Title:	Kit Wong / Shareholder
Date:	03/27/2026

FAQ

What ownership stake does Kit Wong report in Charming Medical (MCTA)?

Kit Wong reports beneficial ownership of 10,350,360 Class A shares and 2,000,000 Class B shares of Charming Medical. This position represents about 69.29% of the Class A shares and gives her a dominant voting stake when combined with the super-voting Class B shares.

How much voting control does Kit Wong hold over Charming Medical (MCTA)?

Kit Wong holds approximately 91.65% of Charming Medical’s aggregate voting power. This stems from her ownership of both Class A shares with one vote each and Class B shares with twenty votes each, effectively giving her control over most shareholder decisions and elections.

What is the share structure of Charming Medical (MCTA) reported in this filing?

The filing cites 14,938,000 Class A ordinary shares and 2,000,000 Class B ordinary shares outstanding. Each Class A share carries one vote, while each Class B share carries twenty votes, creating a dual-class structure that concentrates voting power with Class B holders.

What roles does Kit Wong hold at Charming Medical (MCTA)?

Kit Wong is described as the Chief Executive Officer, a director, and the Chairman of the Board of Charming Medical. Combined with her large voting stake, these roles position her to significantly influence company strategy, governance decisions, and overall corporate direction as disclosed.

Does Kit Wong plan additional transactions or changes at Charming Medical (MCTA)?

The filing states Kit Wong is a pre-IPO shareholder who acquired and holds her shares with the intent to exercise control. Aside from this control intent, she reports no specific current plans for actions listed under Schedule 13D items and no transactions in the past sixty days.

Has Kit Wong disclosed any legal or regulatory issues in connection with Charming Medical (MCTA)?

The disclosure states that during the last five years, Kit Wong has not been convicted in a criminal proceeding and has not been subject to civil judgments or orders involving violations of federal or state securities laws. No related legal issues are reported in this statement.